BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37722393)

  • 1. Anti-GPIb/IX autoantibodies are associated with poor response to dexamethasone combined with rituximab therapy in primary immune thrombocytopenia patients.
    Ding B; Liu L; Li M; Song X; Zhang Y; Xia A; Liu J; Zhou H
    Platelets; 2023 Dec; 34(1):2258988. PubMed ID: 37722393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicenter cohort study.
    Peng J; Ma SH; Liu J; Hou Y; Liu XM; Niu T; Xu RR; Guo CS; Wang XM; Cheng YF; Ni H; Hou M
    J Thromb Haemost; 2014 Apr; 12(4):497-504. PubMed ID: 24517219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between the expression of autoantibodies against platelet membrane glycoprotein and therapeutic effect in primary immune thrombocytopenia].
    Liu XF; Xue F; Zhang L; Zhou XL; Liu YZ; Liu W; Chen YF; Huang YT; Yang RC
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jul; 34(7):610-3. PubMed ID: 23906456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between platelet glycoprotein-specific antibodies and response to short-term high-dose dexamethasone with prednisone maintenance treatment in adult patients with primary immune thrombocytopenia.
    Hou YQ; Wang Y; Liu CX; Li SX; Peng YL; Dong-Dong W; Sa RL
    Ann Med; 2022 Dec; 54(1):132-137. PubMed ID: 36799363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet autoantibody specificity and response to rhTPO treatment in patients with primary immune thrombocytopenia.
    Yu Y; Hou Y; Zhao Y; Zhou H; Jing F; Liu Y; Peng J; Liu X; Hou M
    Br J Haematol; 2021 Jul; 194(1):191-194. PubMed ID: 33993469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the relations between HLA-DRB1 alleles and idiopathic thrombocytopenic purpura in children].
    Wang H; Shen B; Yan W; Hou M; Zhu N; Qi H; Hou H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Aug; 19(4):290-4. PubMed ID: 12170464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of rituximab and dexamethasone on regulatory and proinflammatory B-cell subsets in patients with primary immune thrombocytopenia.
    Gudbrandsdottir S; Brimnes M; Køllgaard T; Hasselbalch HC; Nielsen CH
    Eur J Haematol; 2018 Jan; 100(1):45-52. PubMed ID: 28960473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Levels of T Lymphocyte Subsets in Immune Thrombocytopenia Associated with Anti-GPIIb/IIIa- and/or Anti-GPIbα-Mediated Responses Are Differentially Sensitive to Dexamethasone.
    Chen Y; Xie Y; Ruan M; Shi J
    Acta Haematol; 2018; 140(1):60-66. PubMed ID: 30130794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of circulating B cells producing anti-GPIb autoantibodies in patients with immune thrombocytopenia.
    Kuwana M; Okazaki Y; Ikeda Y
    PLoS One; 2014; 9(1):e86943. PubMed ID: 24466297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of idiopathic thrombocytopenic purpura patients with antiglycoprotein IIb/IIIa or Ib autoantibodies.
    Nomura S; Yanabu M; Soga T; Kido H; Fukuroi T; Yamaguchi K; Nagata H; Kokawa T; Yasunaga K
    Acta Haematol; 1991; 86(1):25-30. PubMed ID: 1950358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fab-mediated binding of glycoprotein Ib/IX and IIb/IIIa specific antibodies in chronic idiopathic thrombocytopenic purpura.
    Hou M; Stockelberg D; Kutti J; Wadenvik H
    Br J Haematol; 1995 Dec; 91(4):944-50. PubMed ID: 8547147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro.
    Chang M; Nakagawa PA; Williams SA; Schwartz MR; Imfeld KL; Buzby JS; Nugent DJ
    Blood; 2003 Aug; 102(3):887-95. PubMed ID: 12676790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulins targeting both GPIIb/IIIa and GPIb/IX in chronic idiopathic thrombocytopenic purpura (ITP): evidence for at least two different IgG antibodies.
    Hou M; Stockelberg D; Kutti J; Wadenvik H
    Br J Haematol; 1997 Jul; 98(1):64-7. PubMed ID: 9233565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships of platelet glycoprotein specific antibody with therapeutic efficacy of short-term high-dose dexamethasone and bleeding score in the newly diagnosed adult patients with primary immune thrombocytopenia.
    Song M; Wang X; Sun M; Wang L; Wang X; Liu Y; Fan W; Li Q; Guo X
    Hematology; 2023 Dec; 28(1):2255801. PubMed ID: 37702365
    [No Abstract]   [Full Text] [Related]  

  • 15. [Participation of bonth splenic CD(5)(+) and CD(5)(-) B lymphocytes in production of platelet glycoprotein-specific autoantibodies in chronic ITP].
    Lu B; Hou M; Lu L; Shi Y; He Q; Ma D; Zhang M
    Zhonghua Xue Ye Xue Za Zhi; 2002 Sep; 23(9):460-2. PubMed ID: 12482355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The impact of platelet membrane autoantibodies on high-dose dexamethasone therapy in patients with idiopathic thrombocytopenic purpura].
    Wang R; Qin P; Ji XB; Hou M
    Zhonghua Xue Ye Xue Za Zhi; 2009 Sep; 30(9):619-21. PubMed ID: 19954623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of rituximab on anti-platelet autoantibody levels in patients with immune thrombocytopenia.
    Arnold DM; Vrbensky JR; Karim N; Smith JW; Liu Y; Ivetic N; Kelton JG; Nazy I
    Br J Haematol; 2017 Jul; 178(2):302-307. PubMed ID: 28444742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between platelet autoantibody specificity and response to intravenous immunoglobulin G in the treatment of patients with immune thrombocytopenia.
    Go RS; Johnston KL; Bruden KC
    Haematologica; 2007 Feb; 92(2):283-4. PubMed ID: 17296593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modern reassessment of glycoprotein-specific direct platelet autoantibody testing in immune thrombocytopenia.
    Al-Samkari H; Rosovsky RP; Karp Leaf RS; Smith DB; Goodarzi K; Fogerty AE; Sykes DB; Kuter DJ
    Blood Adv; 2020 Jan; 4(1):9-18. PubMed ID: 31891657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-specific antibodies and differences in their expression in childhood immune thrombocytopenic purpura predicts clinical progression.
    Fu L; Ma J; Cheng Z; Gu H; Ma J; Wu R
    Pediatr Investig; 2018 Dec; 2(4):230-235. PubMed ID: 32851271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.